161 related articles for article (PubMed ID: 20868293)
1. Emerging drugs for the treatment of tuberculosis.
Yew WW; Cynamon M; Zhang Y
Expert Opin Emerg Drugs; 2011 Mar; 16(1):1-21. PubMed ID: 20868293
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Challenges and opportunities in developing novel drugs for TB.
Kaneko T; Cooper C; Mdluli K
Future Med Chem; 2011 Sep; 3(11):1373-400. PubMed ID: 21879843
[TBL] [Abstract][Full Text] [Related]
4. Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?
Yew WW; Koh WJ
Korean J Intern Med; 2016 Jan; 31(1):15-29. PubMed ID: 26767853
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of tuberculosis].
Eier A; Grass S
Wien Med Wochenschr; 1994; 144(8-9):186-8. PubMed ID: 7941607
[TBL] [Abstract][Full Text] [Related]
6. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes.
Lienhardt C; Vernon A; Raviglione MC
Curr Opin Pulm Med; 2010 May; 16(3):186-93. PubMed ID: 20216421
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
8. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
[TBL] [Abstract][Full Text] [Related]
9. Treatment of tuberculosis: update 2010.
Yew WW; Lange C; Leung CC
Eur Respir J; 2011 Feb; 37(2):441-62. PubMed ID: 20847074
[TBL] [Abstract][Full Text] [Related]
10. [Reasons for drug-resistant tuberculosis emergence].
Tu DH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
[No Abstract] [Full Text] [Related]
11. Clofazimine in the treatment of multidrug-resistant tuberculosis.
Xu HB; Jiang RH; Xiao HP
Clin Microbiol Infect; 2012 Nov; 18(11):1104-10. PubMed ID: 22192631
[TBL] [Abstract][Full Text] [Related]
12. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
Park SK; Kim CT; Song SD
Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607
[TBL] [Abstract][Full Text] [Related]
13. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
[TBL] [Abstract][Full Text] [Related]
14. New treatment options for multidrug-resistant tuberculosis.
Field SK; Fisher D; Jarand JM; Cowie RL
Ther Adv Respir Dis; 2012 Oct; 6(5):255-68. PubMed ID: 22763676
[TBL] [Abstract][Full Text] [Related]
15. [Maxaquin in the combined treatment of tuberculosis].
Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI
Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850
[TBL] [Abstract][Full Text] [Related]
16. [Long-term results of treatment of drug-resistant pulmonary tuberculosis in adolescents].
Firsova VA; Poluĕktova FG; Ryzhova AP
Probl Tuberk Bolezn Legk; 2005; (7):25-8. PubMed ID: 16130423
[TBL] [Abstract][Full Text] [Related]
17. Extensively drug-resistant tuberculosis: new strains, new challenges.
Banerjee R; Schecter GF; Flood J; Porco TC
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
[TBL] [Abstract][Full Text] [Related]
18. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000-2003)].
Chevalier B; Margery J; Sane M; Camara P; Lefebvre N; Gueye M; Thiam M; Perrier-Gros-Claude JD; Simon F; Fabre M; Soler C; Herve V; Mbaye PS; Debonne JM
Rev Pneumol Clin; 2010 Sep; 66(4):266-71. PubMed ID: 20933169
[TBL] [Abstract][Full Text] [Related]
20. New drugs for tuberculosis.
Grassi C; Peona V
Eur Respir J Suppl; 1995 Sep; 20():714s-718s. PubMed ID: 8590571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
